PetVivo Holdings PETV
OTC PETV
$0.69 +0.00 (+0.00%)
At close: Oct 22, 2026 · 4:00 PM EDT

PetVivo Holdings (PETV) EBITDA Margin (2015 - 2026)

Updated

PetVivo Holdings (PETV) recorded EBITDA Margin of -436.70% in fiscal Q1 2027 (quarter ended Jun 30, 2026), up 143.61 percentage points from -580.31% a year earlier and up 673.02 percentage points from the prior quarter.

Analysis

PetVivo Holdings (PETV) EBITDA Margin (2015 - 2026) Analysis & Trends

On a TTM basis, PetVivo Holdings' EBITDA Margin came in at -702.33% as of Jun 30, 2026, down 120.78 percentage points year-over-year; for FY2026 (ended Mar 31, 2026), it came in at -749.08%, down 53.19 percentage points from FY2025.

  • Annual EBITDA Margin has a five-year change of +14136.25 percentage points (FY2021 to FY2026).
  • Across earlier fiscal years, EBITDA Margin came in at -695.89% in FY2025 (+387.47 pp), -1083.35% in FY2024 (-143.60 pp), -939.75% in FY2023 (+3378.57 pp) and -4318.32% in FY2022 (+10567.00 pp).
  • The fiscal Q1 2027 figure is the highest quarterly EBITDA Margin since fiscal Q3 2025.
  • On a year-over-year basis, EBITDA Margin rose in six of the last eight quarters, with an average year-over-year change of +737.26 percentage points.
  • Peak year-over-year performance for EBITDA Margin in the last five years was a gain of 70348.95 percentage points in fiscal Q3 2022, against a drop of 4981.88 percentage points in fiscal Q2 2022 at the low end.
  • Per Business Quant, the preceding three fiscal quarters came in at -1109.72% (Q4 2026), -718.87% (Q3 2026) and -640.23% (Q2 2026).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA Margin (Qtr)
1 Eli Lilly 1,230.11 Bn 1,198.70 Bn 19.71 Bn 53.49%
2 Johnson & Johnson 644.39 Bn 564.25 Bn 17.30 Bn 32.68%
3 AbbVie 503.52 Bn 476.68 Bn 12.70 Bn 49.01%
4 Merck 363.29 Bn 317.72 Bn 12.21 Bn 6.02%
5 Novartis Ag 298.23 Bn 262.62 Bn 11.24 Bn -
6 Astrazeneca 267.53 Bn 241.29 Bn 12.86 Bn 33.11%
7 Amgen 241.80 Bn 197.20 Bn 7.24 Bn 46.01%
8 Gilead Sciences 195.07 Bn 169.19 Bn 6.22 Bn -124.26%
9 Pfizer 173.33 Bn 120.28 Bn 10.94 Bn 39.16%
10 PetVivo Holdings 26.19 Mn 24.93 Mn 223,317.00 -431.94%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -431.94%
Mar 31, 2026 -751.32%
Dec 31, 2025 -717.83%
Sep 30, 2025 -353.28%
Jun 30, 2025 -558.04%
Mar 31, 2025 -812.12%
Dec 31, 2024 -295.95%
Sep 30, 2024 -1,066.16%
Jun 30, 2024 -1,624.98%
Mar 31, 2024 -5,421.28%
Dec 31, 2023 -352.97%
Sep 30, 2023 -1,404.34%
Jun 30, 2023 -2,442.70%
Mar 31, 2023 -1,836.26%
Dec 31, 2022 -448.05%
Sep 30, 2022 -935.42%
Jun 30, 2022 -3,332.31%
Mar 31, 2022 -3,164.47%
Dec 31, 2021 -3,219.69%
Sep 30, 2021 -21,886.00%
API Access

PetVivo Holdings EBITDA Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebitda-margin&ticker=PETV&period=max&api_key=YOUR_API_KEY